Company News, Financial News

Croda Completes Solus Biotech Acquisition

Will enhance company’s synthetic ceramides portfolio delivered by Sederma, drawing on Solus’ existing biotech-derived ceramide and phospholipid technologies.

Author Image

By: Lianna Albrizio

Associate Editor

Croda International Plc – the company that uses smart science to create high-performance ingredients and solutions that improve lives – has completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived beauty actives.   The move will enhance the company’s current synthetic ceramides portfolio delivered by Sederma, drawing on Solus’ existing biotech-derived ceramide and phospholipid technologies, officials said. Located in South Korea, Solus will expand Cro...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters